Board Change | 24-Mar-2023 | 13:35 | RNS |
Results of AGM | 24-Mar-2023 | 13:30 | RNS |
Positive FDA Feedback to Progress Bexmarilimab | 22-Mar-2023 | 07:00 | RNS |
Notice of Faron Pharmaceuticals Ltd’s AGM | 03-Mar-2023 | 09:00 | RNS |
Faron´s Annual Report 2022 Published | 03-Mar-2023 | 07:15 | RNS |
Financial Statement January 1 to December 31 2022 | 03-Mar-2023 | 07:00 | RNS |
Update to Faron’s Financial Calendar for 2... | 06-Feb-2023 | 18:00 | RNS |
Holding(s) in Company | 01-Feb-2023 | 15:45 | RNS |
Holding(s) in Company | 27-Jan-2023 | 17:45 | RNS |
Results of Placing | 27-Jan-2023 | 07:00 | RNS |
Proposed Issue and Placing | 26-Jan-2023 | 16:30 | RNS |
Price Monitoring Extension | 16-Jan-2023 | 11:00 | RNS |
Second Price Monitoring Extn | 16-Jan-2023 | 09:05 | RNS |
Price Monitoring Extension | 16-Jan-2023 | 09:00 | RNS |
Title: BEXMAB study update | 16-Jan-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 315.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 375.00 |
52 Week Low | 160.00 |
Volume | 12,385 |
Shares Issued | 63.50m |
Market Cap | £200.02m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
15:38 | 1,033 @ 309.50p |
13:50 | 100 @ 309.40p |
13:38 | 7,735 @ 305.00p |
12:41 | 1,000 @ 318.40p |
11:24 | 305 @ 310.20p |
You are here: research